Toshiyuki Kitai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Toshiyuki Kitai has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Mitsuharu Miwa
Central Laboratory, Hamamatsu Photonics
1 shared publicationTakahiro Shikayama
Central Laboratory, Hamamatsu Photonics
1 shared publicationTakuya Inomoto
Osaka Red Cross Hospital
1 shared publication
Latest Publications
- Open Access
- 12 July 2012
- Published by Hindawi Limited in Gastroenterology Research and Practice
- Vol. 2012, 1-6
Pulmonary Metastasis from Pseudomyxoma Peritonei
Pseudomyxoma peritonei (PMP) is a rare clinical condition, where copious mucinous ascites accumulate in the peritoneal cavity due to dissemination of mucin-producing tumor. Because of this disseminating, yet nonmetastasizing, behavior, PMP attracts much interest from surgical oncologists in that aggressive locoregional therapy can give the opportunity of long survival and even cure. Although extra-abdominal metastasis is exceptionally rare, the lung is the most likely site in such a case. In this paper, the clinical findings and treatment of eleven cases with pulmonary metastasis from PMP were reviewed, including ten cases in the literature and one case which we experienced. The clinical features of PMP cases with pulmonary metastasis were similar to cases without pulmonary metastasis. The histological type was low-grade mucinous neoplasm in most cases. Pulmonary lesions were resected in seven cases in which abdominal lesions were controlled by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy or another therapeutic modality. Disease-free state was maintained in five cases at the end of the follow-up period. However, it should be noted that rapid progression after resection was seen in two cases, suggesting that biological features may have changed by surgical intervention.
- 12 July 2012
- Published by Hindawi Limited in Gastroenterology Research and Practice
- Vol. 2012, 1-6
Open AccessPulmonary Metastasis from Pseudomyxoma Peritonei
Pseudomyxoma peritonei (PMP) is a rare clinical condition, where copious mucinous ascites accumulate in the peritoneal cavity due to dissemination of mucin-producing tumor. Because of this disseminating, yet nonmetastasizing, behavior, PMP attracts much interest from surgical oncologists in that aggressive locoregional therapy can give the opportunity of long survival and even cure. Although extra-abdominal metastasis is exceptionally rare, the lung is the most likely site in such a case. In this paper, the clinical findings and treatment of eleven cases with pulmonary metastasis from PMP were reviewed, including ten cases in the literature and one case which we experienced. The clinical features of PMP cases with pulmonary metastasis were similar to cases without pulmonary metastasis. The histological type was low-grade mucinous neoplasm in most cases. Pulmonary lesions were resected in seven cases in which abdominal lesions were controlled by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy or another therapeutic modality. Disease-free state was maintained in five cases at the end of the follow-up period. However, it should be noted that rapid progression after resection was seen in two cases, suggesting that biological features may have changed by surgical intervention.
- 1 July 2005
- Published by Springer Nature in Breast Cancer
- Vol. 12 (3) , 211-215
Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer
Background Sentinel lymph node biopsy using a vital dye is a convenient and safe method to assess lymph node status in breast cancer. However, intensive training is necessary to obtain a satisfactory...
- 1 July 2005
- Published by Springer Nature in Breast Cancer
- Vol. 12 (3) , 211-215
Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer
Background Sentinel lymph node biopsy using a vital dye is a convenient and safe method to assess lymph node status in breast cancer. However, intensive training is necessary to obtain a satisfactory...